Advertisement

Anatomy and Target Delineation: Definitive and Postoperative Adjuvant Radiation Therapy in Vulvar Cancer

Chapter
  • 658 Downloads
Part of the Practical Guides in Radiation Oncology book series (PGRO)

Abstract

Vulvar cancer is a relatively rare, complex tumor site to treat. Surgery, radiation, and chemotherapy all play a significant role in achieving cure and lasting locoregional control. Due to the substantial morbidity and mortality associated with uncontrolled or recurrent disease, careful attention to target volumes and a good understanding of patterns of spread are crucial in optimizing outcomes for these patients. This chapter provides guidance on the appropriate target volumes, treatment dose, and normal tissue dose constraints for this tumor site.

Keywords

Vulvar cancer External beam radiotherapy (EBRT) Intensity-modulated radiotherapy (IMRT) Target delineation Clinical target volume (CTV) Lymph nodes 

References

  1. 1.
    Perez CA, Grigsby PW, Chao KC, Galakatos A, Garipagaoglu M, Mutch D, et al. Irradiation in carcinoma of the vulva: factors affecting outcome. Int J Radiat Oncol Biol Phys. 1998;42(2):335–44.PubMedCrossRefGoogle Scholar
  2. 2.
    Barnes E, Thomas G. Integrating radiation into the management of vulvar cancer. Semin Radiat Oncol. 2006;16(3):168–76.PubMedCrossRefGoogle Scholar
  3. 3.
    Kidd E, Moore D, Varia MA, Gaffney DK, Elshaikh MA, Erickson B, et al. ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva. Am J Clin Oncol. 2013;36(4):415–22.PubMedCrossRefGoogle Scholar
  4. 4.
    Nooij LS, Brand FAM, Gaarenstroom KN, Creutzberg CL, de Hullu JA, van Poelgeest MIE. Risk factors and treatment for recurrent vulvar squamous cell carcinoma. Crit Rev Oncol Hematol. 2016;106:1–13.PubMedCrossRefGoogle Scholar
  5. 5.
  6. 6.
    Iversen T, Aas M. Lymph drainage from the vulva. Gynecol Oncol. 1983;16(2):179–89.PubMedCrossRefGoogle Scholar
  7. 7.
    Rose PG. Skin bridge recurrences in vulvar cancer: frequency and management. Int J Gynecol Cancer. 1999;9(6):508–11.PubMedCrossRefGoogle Scholar
  8. 8.
    Rouzier R, Haddad B, Plantier F, Dubois P, Pelisse M, Paniel BJ. Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet Gynecol. 2002;100(6):1159–67.PubMedGoogle Scholar
  9. 9.
    de Hullu JA, Hollema H, Lolkema S, Boezen M, Boonstra H, Burger MPM, et al. Vulvar carcinoma: the price of less radical surgery. Cancer. 2002;95(11):2331–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Kürzl R, Messerer D. Prognostic factors in squamous cell carcinoma of the vulva: a multivariate analysis. Gynecol Oncol. 1989;32(2):143–50.PubMedCrossRefGoogle Scholar
  11. 11.
    Dusenbery KE, Carlson JW, Laporte RM, Unger JA, Goswitz JJ, Roback DM, et al. Radical vulvectomy with postoperative irradiation for vulvar cancer: therapeutic implications of a central block. Int J Radiat Oncol Biol Phys. 1994;29(5):989–98.CrossRefGoogle Scholar
  12. 12.
    Faul CM, Mirmow D, Huang Q, Gerszten K, Day R, Jones MW. Adjuvant radiation for vulvar carcinoma: improved local control. Int J Radiat Oncol Biol Phys. 1997;38(2):381–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Chan JK, Sugiyama V, Pham H, Gu M, Rutgers J, Osann K, et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol. 2007;104(3):636–41.PubMedCrossRefGoogle Scholar
  14. 14.
    Aragona AM, Cuneo NA, Soderini AH, Alcoba EB. An analysis of reported independent prognostic factors for survival in squamous cell carcinoma of the vulva: is tumor size significance being underrated? Gynecol Oncol. 2014;132(3):643–8.PubMedCrossRefGoogle Scholar
  15. 15.
    ESGO. European Society of Gynaecological Oncology guidelines for the management of patients with vulvar cancer [Internet]. 2016 [cited 2017 May 1]. p. 832–837. http://journals.lww.com/ijgc/Abstract/2017/05000/European_Society_of_Gynaecological_Oncology.31.aspx.
  16. 16.
    Ignatov T, Eggemann H, Burger E, Costa SD, Ignatov A. Adjuvant radiotherapy for vulvar cancer with close or positive surgical margins. J Cancer Res Clin Oncol. 2016;142(2):489–95.PubMedCrossRefGoogle Scholar
  17. 17.
    National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Vulvar cancer, Version 1.2017. 2016.Google Scholar
  18. 18.
    Viswanathan AN, Pinto AP, Schultz D, Berkowitz R, Crum CP. Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol. 2013;130(3):545–9.PubMedCrossRefGoogle Scholar
  19. 19.
    te Grootenhuis NC, van der Zee AGJ, van Doorn HC, van der Velden J, Vergote I, Zanagnolo V, et al. Sentinel nodes in vulvar cancer: long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol. 2016;140(1):8–14.CrossRefGoogle Scholar
  20. 20.
    Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol. 1986;68(6):733–40.PubMedGoogle Scholar
  21. 21.
    Katz A, Eifel PJ, Jhingran A, Levenback CF. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys. 2003;57(2):409–18.PubMedCrossRefGoogle Scholar
  22. 22.
    Kunos C, Simpkins F, Gibbons H, Tian C, Homesley H. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol. 2009;114(3):537–46.CrossRefGoogle Scholar
  23. 23.
    Mahner S, Jueckstock J, Hilpert F, Neuser P, Harter P, de Gregorio N, et al. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst. 2015;107(3):dju426.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Fons G, Groenen SMA, Oonk MHM, Ansink AC, van der Zee AGJ, Burger MPM, et al. Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial. Gynecol Oncol. 2009;114(2):343–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Parthasarathy A, Cheung MK, Osann K, Husain A, Teng NN, Berek JS, et al. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Gynecol Oncol. 2006;103(3):1095–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys. 1998;42(1):79–85.PubMedCrossRefGoogle Scholar
  27. 27.
    Montana GS, Thomas GM, Moore DH, Saxer A, Mangan CE, Lentz SS, et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys. 2000;48(4):1007–13.PubMedCrossRefGoogle Scholar
  28. 28.
    Moore DH, Ali S, Koh W-J, Michael H, Barnes MN, McCourt CK, et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study. Gynecol Oncol. 2012;124(3):529–33.CrossRefGoogle Scholar
  29. 29.
    Gay HA, Barthold HJ, O’Meara E, Bosch WR, El Naqa I, Al-Lozi R, et al. Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys. 2012;83(3):e353–62.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Gaffney DK, King B, Viswanathan AN, Barkati M, Beriwal S, Eifel P, et al. Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma. Int J Radiat Oncol Biol Phys. 2016;95(4):1191–200.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Wang CJ, Chin YY, Leung SW, Chen HC, Sun LM, Fang FM. Topographic distribution of inguinal lymph nodes metastasis: significance in determination of treatment margin for elective inguinal lymph nodes irradiation of low pelvic tumors. Int J Radiat Oncol Biol Phys. 1996;35(1):133–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Taylor A, Rockall AG, Powell MEB. An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition. Clin Oncol. 2007;19(7):542–50.CrossRefGoogle Scholar
  33. 33.
    Small W, Mell LK, Anderson P, Creutzberg C, De Los SJ, Gaffney D, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71(2):428–34.CrossRefGoogle Scholar
  34. 34.
    Kim CH, Olson AC, Kim H, Beriwal S. Contouring inguinal and femoral nodes; how much margin is needed around the vessels? Pract Radiat Oncol. 2012;2(4):274–8.CrossRefGoogle Scholar
  35. 35.
    Beriwal S, Heron DE, Kim H, King G, Shogan J, Bahri S, et al. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. Int J Radiat Oncol Biol Phys. 2006;64(5):1395–400.PubMedCrossRefGoogle Scholar
  36. 36.
    D’Souza DP, Rumble RB, Fyles A, Yaremko B, Warde P. Intensity-modulated radiotherapy in the treatment of gynaecological cancers. Clin Oncol. 2012 Sep;24(7):499–507.CrossRefGoogle Scholar
  37. 37.
    Gill BS, Bernard ME, Lin JF, Balasubramani GK, Rajagopalan MS, Sukumvanich P, et al. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: a National Cancer Data Base (NCDB) analysis. Gynecol Oncol. 2015;137(3):365–72.PubMedCrossRefGoogle Scholar
  38. 38.
    Beriwal S, Shukla G, Shinde A, Heron DE, Kelley JL, Edwards RP, et al. Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse. Int J Radiat Oncol Biol Phys. 2013;85(5):1269–74.PubMedCrossRefGoogle Scholar
  39. 39.
    Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, et al. NRG Oncology/RTOG 0921: a phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Cancer. 2015;121(13):2156–63.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Chapman BV, Gill BS, Viswanathan AN, Balasubramani GK, Sukumvanich P, Beriwal S. Adjuvant radiation therapy for margin-positive vulvar squamous cell carcinoma: defining the ideal dose-response using the National Cancer Data Base. Int J Radiat Oncol Biol Phys. 2017;97(1):107–17.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Radiation Oncology and Molecular Radiation SciencesJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Department of Radiation OncologyUniversity of North Carolina School of MedicineChapel HillUSA

Personalised recommendations